Tenon Medical, Inc.
TNON
$1.17
$0.021.74%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 11.92% | 38.30% | 103.01% | 205.22% | 323.73% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 11.92% | 38.30% | 103.01% | 205.22% | 323.73% |
| Cost of Revenue | -7.17% | -27.26% | -26.28% | -5.27% | 26.65% |
| Gross Profit | 37.87% | 303.58% | 1,420.78% | 463.22% | 293.60% |
| SG&A Expenses | -6.74% | -26.99% | -22.33% | -24.56% | -5.97% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -8.64% | -25.59% | -21.71% | -20.22% | -0.99% |
| Operating Income | 12.47% | 33.05% | 31.87% | 31.54% | 13.35% |
| Income Before Tax | 12.25% | 32.59% | 31.32% | 33.03% | 17.63% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 12.25% | 32.59% | 31.32% | 33.03% | 17.63% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 12.25% | 32.59% | 31.32% | 33.03% | 17.63% |
| EBIT | 12.47% | 33.05% | 31.87% | 31.54% | 13.35% |
| EBITDA | 13.97% | 34.50% | 33.12% | 32.55% | 14.08% |
| EPS Basic | 72.27% | 75.35% | 71.49% | 65.00% | 74.39% |
| Normalized Basic EPS | 72.27% | 75.35% | 71.49% | 63.81% | 73.95% |
| EPS Diluted | 72.27% | 75.35% | 71.49% | 65.00% | 74.39% |
| Normalized Diluted EPS | 72.27% | 75.35% | 71.49% | 63.81% | 73.95% |
| Average Basic Shares Outstanding | 435.69% | 176.94% | 144.13% | 112.93% | 127.14% |
| Average Diluted Shares Outstanding | 435.69% | 176.94% | 144.13% | 112.93% | 127.14% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |